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Herpes simplex virus type-1 expresses a heterodimeric Fc receptor, gE-gI, on the surfaces of virions and infected cells
that binds the Fc region of host immunoglobulin G and is implicated in the cell-to-cell spread of virus. gE-gI binds
immunoglobulin G at the basic pH of the cell surface and releases it at the acidic pH of lysosomes, consistent with a role
in facilitating the degradation of antiviral antibodies. Here we identify the C-terminal domain of the gE ectodomain
(CgE) as the minimal Fc-binding domain and present a 1.78-A˚ CgE structure. A 5-A˚ gE-gI/Fc crystal structure, which was
independently verified by a theoretical prediction method, reveals that CgE binds Fc at the CH2-CH3 interface, the
binding site for several mammalian and bacterial Fc-binding proteins. The structure identifies interface histidines that
may confer pH-dependent binding and regions of CgE implicated in cell-to-cell spread of virus. The ternary
organization of the gE-gI/Fc complex is compatible with antibody bipolar bridging, which can interfere with the
antiviral immune response.
Citation: Sprague ER, Wang C, Baker D, Bjorkman PJ (2006) Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging. PLoS
Biol 4(6): e148. DOI: 10.1371/journal.pbio.0040148
Introduction
Herpes simplex virus type-1 (HSV-1) has evolved several
strategies to escape detection by the host’s immune system,
including the expression of an Fc receptor (FcR) called gE-gI
that is found on the surface of virions and infected cells [1–3].
gE-gI binds the Fc region of immunoglobulin G (IgG), likely
interfering with antibody-mediated viral clearance [4].
Previous studies suggested that anti-HSV IgG antibodies
participate in antibody bipolar bridging, whereby an anti-
body molecule simultaneously binds to gE-gI with its Fc
region and to a specific HSV-antigen (e.g., gC or gD) with its
Fab arms [5–8]. Antibody bipolar bridging has been shown to
protect the virus and infected cells from IgG-mediated
immune responses, such as antibody- and complement-
dependent neutralization [6], antibody-dependent cell-medi-
ated cytotoxicity [5], and granulocyte attachment [8]. Experi-
ments in HSV-1–infected mice comparing the effectiveness of
human anti-HSV IgG versus nonimmune IgG or murine anti-
HSV IgG (which does not bind gE-gI) have provided support
for the importance of antibody bipolar bridging mediated by
gE-gI [7]. gE-gI has also been implicated in the cell-to-cell
spread of HSV, although the relationship between IgG
binding and cell-to-cell spread remains unclear [9,10].
HSV-1 gE-gI is a heterodimer composed of two type I
membrane glycoproteins: gE, a 530-residue protein including
a ;401-residue extracellular region followed by a predicted
single transmembrane helix and a ;106-residue C-terminal
cytoplasmic tail; and gI, a 370-residue protein including a
;248-residue extracellular portion followed by a predicted
single transmembrane helix, and a ;94-residue C-terminal
cytoplasmic tail. The cytoplasmic tails of both gE and gI
contain potential endocytosis motifs, and studies of gE and gI
in HSV-1 and other alphaherpesviruses have demonstrated
that gE, gI, and gE-gI undergo endocytosis and recycling [11].
The discovery that gE-gI binding to Fc is sharply pH
dependent, such that binding is observed at neutral or
slightly basic pH but not at acidic pH, suggests that IgG
bound by cell-surface gE-gI would dissociate if endocytosed
together with gE-gI into intracellular vesicles [12]. In
addition, the pH dependence of the gE-gI/Fc interaction
allows speculation that the participation of gE-gI in antibody
bipolar bridging plays an active role in clearing the cell
surface of host IgG and of viral antigens, whereby endocytosis
of HSV antigens bound to gE-gI–associated anti-HSV IgG is
followed by dissociation of the IgG-antigen complexes in
degradative compartments such as lysosomes.
Several studies have identified regions of gE, gI, and Fc that
are critical to the gE-gI and gE-gI/IgG interactions. Although
the gE-gI heterodimer is required for high-affinity binding of
monomeric IgG, gE alone is a low-affinity FcR that binds
isolated Fc [12] as well as IgG in immune complexes, such as
IgG-coated erythrocytes [1,13]. Because isolated gI binds
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neither free IgG nor IgG in immune complexes [13], it is
unlikely to contain a significant Fc binding interface. The Fc
binding region on gE has been localized to the C-terminal
domain of the gE ectodomain (CgE) [14,15], whereas the N-
terminal domain of gE (NgE) associates with gI, forming a
complex that does not bind to IgG [16]. The region of the gE-
gI heterodimer that is important for cell-to-cell spread of
HSV has also been mapped to CgE [17,18].
The gE-gI-binding site on IgG has been localized to the Fc
CH2-CH3 interdomain hinge, a ‘‘hot spot’’ that serves as the
binding site for several other mammalian and bacterial Fc-
binding proteins [19,20]. Residues critical to the interaction
were identified in binding studies comparing the affinities of
human IgG subtypes for gE-gI, which found that gE-gI binds to
IgG1, IgG2, and IgG4 with similar affinities (equilibrium
dissociation constant [KD] ;40–400 nM), but does not bind
several IgG3 allotypes or an IgG4 mutant in which His435 was
changed to an arginine [21,22]. These results implicate a role
for Fc His435, which is an arginine in most human IgG3
allotypes, and are consistent with a previous suggestion that
gE-gI and protein A have overlapping binding sites at the CH2-
CH3 domain interface of Fc [23]. Additional studies using a
nonbinding Fc mutant (nbFc), which contains six point
mutations in the CH2-CH3 hinge, confirmed the gE-gI binding
site on Fc and established the stoichiometry as two gE-gI
heterodimers per one Fc dimer (2:1) [12], analogous to the
binding stoichiometries for all known FcR/Fcc interactions
that involve the Fc CH2-CH3 domain interface [19,24–28].
In order to study the interaction between gE-gI and Fc in
more detail, we initiated structural studies of gE, gE-gI, and a
gE-gI/Fc complex. gE-gI heterodimers are resistant to
crystallization, but we were able to determine structures of
a gE fragment and a gE-gI complex with Fc. Here we describe
the 1.78-A˚ crystal structure of CgE, demonstrate that CgE
binds to Fc, and present a low-resolution structure of a gE-gI/
Fc complex. The binding mode observed for Fc and the CgE
portion of gE-gI in the gE-gI/Fc crystal structure was verified
by an independent theoretical prediction of the CgE
interaction with Fc. The gE-gI/Fc model resulting from
prediction and crystallographic methods is consistent with
biochemical data characterizing the interaction, provides
insight into the molecular basis for the observed pH
dependence of the gE-gI/Fc interaction, and allows mapping
of CgE residues important for IgG binding and cell-to-cell
spread. In addition, the orientation of the gE-gI/IgG complex
on a membrane, as predicted from the complex crystal
structure, demonstrates that antibody bipolar bridging can
occur on the surface of an infected cell or virus.
Results
CgE Binds Fc in the Absence of Other gE or gI Domains
Previous studies of the gE-gI/IgG and gE/IgG interactions
localized the Fc-binding region of gE to residues 235–380,
which are contained within CgE [14,15]. To determine
whether isolated CgE (gE residues 213–390, where residue 1
is the first residue of the hydrophobic leader peptide in the
immature gE and residue 420 is the first residue of the
predicted transmembrane region) binds Fc and to measure
the affinity of the interaction, we performed a surface
plasmon resonance assay using two forms of recombinant
Fc derived from human IgG1: wild-type Fc (wtFc) and nbFc,
which contains six point mutations in the CH2-CH3 linker
that abrogate binding to gE-gI (Met252 to Gly, Ile253 to Gly,
His310 to Glu, His433 to Glu, His435 to Glu, and Tyr436 to
Ala) [12]. The Fc proteins were immobilized on the surface of
a biosensor chip, and the binding of CgE was assayed at pH 8
and pH 6. Significant binding of CgE to nbFc was not
observed under any conditions (unpublished data), but CgE
binds wtFc with a KD of ;7 lM at pH 8 (Figure 1A and 1C).
The relatively low affinity of the CgE/Fc interaction likely
explains why a CgE/Fc binding interaction was not detectable
by coimmunoprecipitation analyses [16]. The affinity of CgE
for Fc is similar to that determined for the interaction of gE
with Fc at pH 8 (KD ;30 lM), but ;50-fold weaker than the
affinity of the gE-gI/Fc interaction, which has KD values of 340
nM and 930 nM for the first and second binding sites on wtFc,
respectively [12]. As previously observed for the interaction
of gE-gI with Fc [12], the binding of CgE to Fc is much weaker
at pH 6 than at pH 8 (Figure 1A and 1B). In combination with
previous data, these results suggest that the gI chain
contributes to the gE-gI interaction with Fc either directly
or through stabilizing the binding conformation of gE, that
NgE does not contribute to Fc binding, and that at least some
of the pH dependence of the gE-gI interaction with Fc can be
attributed to the CgE/Fc interface.
Structure of the Fc-Binding Domain of gE
The structure of CgE was determined to 1.78 A˚ by multiple
anomalous dispersion using a crystal of selenomethionine
(SeMet)–substituted CgE (Table S1). CgE is composed
primarily of 14 b-strands organized into three b-sheets, two
of which pack together in a manner resembling an Ig variable
(V) fold (Figure 2A and 2B). The first and second b-sheets in
CgE, which correspond to their counterparts in Ig V domains,
contain strands A, B, B9, E, and D, and strands A9, G, F, C, C9,
and C99, respectively. A third sheet, which is not found in Ig V
domains or other Ig superfamily members, is a parallel b-
sheet containing strands CI, CI9, and I99 (strands denoted with
Figure 1. Binding of CgE to Fc at pH 8 and pH 6
(A and B) Sensorgrams collected from the indicated concentrations of
CgE injected at pH 8 (A) or pH 6 (B) over a flow cell coupled with wtFc.
(C) Plot of equilibrium-binding response (Req) versus concentration of
CgE at pH 8 derived from biosensor data shown in (A). The best-fit
binding curve to the experimental data points (open circles) is shown as
a continuous line.
DOI: 10.1371/journal.pbio.0040148.g001
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‘‘I’’ are part of the ‘‘inserted’’ b-sheet, with strands CI and CI9
proceeding strand C) (Figure 2A and 2B). The third b-sheet
packs against the backside of the A9GFCC9C99 sheet on the
opposite face from the DEBB9A sheet (Figure 2A).
A 3-D search of the protein database using the DALI server
[29] identified the coxsackie virus and adenovirus receptor
domain 1 (pdb entry 1eaj) and a mouse Fv (pdb entry 1mfa) as
two of its closest structural neighbors, with root mean square
deviations of 2.6 A˚ over 108 Ca atoms and 2.8 A˚ over 106 Ca
atoms, respectively (Figure S1). The structural similarity
between CgE and its structural homologs does not include
the third b-sheet found in CgE. In addition, CgE contains
disulfide bonds that are not typically found in Ig superfamily
folds: Cys271–Cys297, which joins the N-terminal ends of the
CI and CI9 strands; Cys280–Cys289, between residues within
the helices near the CI and CI9 strands; and Cys314–Cys323,
between residues within the complementarity-determining
region 2 (CDR2) loop (Figure 2A and 2B). The CgE fold lacks
the disulfide bond that joins the A9GFCC9C99 and the DEBB9A
sheets in the canonical Ig fold, with CgE containing a cysteine
in strand F (Cys359) but a valine in the complementary
position in strand B (Val244). However, the conserved
tryptophan normally found in strand C adjacent to the
intersheet disulfide bond is present in CgE (Trp262). Further
structural differences include the extension of strands C, C9,
and C99 as well as the A9–B and C9–C99 loops, and the
shortening of strands D and E as compared to a representa-
tive Ig V domain (Figure S1A), which leads to a more open
organization of the first two b-sheets (sheets DEBB9A and
A9GFCC9C99). In addition, the DEBB9A sheet is a ‘‘split’’ b-
sheet composed of two smaller b-structures (strands DEB and
B9A) linked by the split B/B9 strand (Figure 2A and 2B).
Comparison with Other FcRs
Other IgG receptors of known structure, which include the
mammalian FccR proteins found on the surface of immune
cells, also belong to the Ig superfamily (reviewed in [30]).
Structural similarity between CgE and host FccRs was
suggested based on a 38-residue region of sequence similarity
(46% amino acid identity between human FccRII residues
109–154 and gE residues 322–359) and the spacing between
gE residues Cys323 and Cys359, which is similar to the typical
spacing between cysteines in the disulfide bond linking
strands B and F in Ig folds [14]. However, CgE has an Ig V
folding topology, whereas host Ig superfamily FccRs are C2-
Figure 2. Structure of CgE
(A) Ribbon diagram of the CgE structure. b-strands D, E, B, B9, and A are light blue, strands A9,G, F, C, C9, and C99 are dark blue, strands CI9, CI, and I99 are
pink, a-helical regions are gray, disulfide bonds are yellow, and the three CDR loops (as defined in Ig V domain structures) are red. All figures depicting
protein structures were generated with PyMOL (The PyMOL Molecular Graphics System, http://www.pymol.org).
(B) CgE topology diagram. b-strands are shown as arrows (colored as in [A]), and helices are shown as gray cylinders. Cysteines are shown as yellow
circles with disulfide bonds indicated by yellow lines between paired cysteines.
(C) Ribbon diagram of CgE with Fc-binding residues highlighted. b-sheets are colored as in (A) (D E B B9 A, light blue; A9 G F C C9 C99, dark blue; and CI9
CI I99, pink), and side chains in the predicted Fc-binding interface (see text) are in magenta. Disulfide bonds are in yellow.
(D) Ribbon diagram of FccRIII with Fc-binding residues highlighted. b-sheets for FccRIII (pdb entry 1e4j) are colored similar to (C) (E B A, light blue; and
A9 G F C C9, dark blue), and side chains in the Fc-binding interface [44] are in magenta. Disulfide bonds are in yellow.
DOI: 10.1371/journal.pbio.0040148.g002
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type Ig domains (reviewed in [30]). As a result, the 38-residue
region of sequence similarity does not adopt a similar
structure in CgE and the FccRs: CgE residues 322–359
encompass strands C99, D, E, and F, whereas strands C99 and
D are absent in C2-type Ig domains, and the predicted
Cys323-Cys359 disulfide bond [14] is not present; instead
Cys323 is in a disulfide bond with Cys314, and Cys359 is not
bonded to another cysteine (Figure 2C and 2D).
The only other FcR of known structure to adopt an Ig V
domain fold is the polymeric Ig receptor (pIgR), which
contains an N-terminal V-like domain that binds to polymeric
IgA and IgM [31]. A comparison of the CgE and pIgR domain 1
structures does not reveal significant similarity beyond a
region of common folding topology (unpublished data).
Differences between the pIgR and CgE Ig V folds include the
positions of the CDR loops, the predicted Fc-binding sites
(described for CgE below), the overall size, with CgE being
larger due to its extended strands C, C9, and C99, and the third
b-sheet in CgE, which is absent in pIgR domain 1.
Crystal Structure of a gE-gI/Fc Complex
Attempts to crystallize a gE-gI heterodimer or gE alone
were unsuccessful (ERS, unpublished data), thus we concen-
trated our efforts on obtaining a structure of a gE-gI/Fc
complex. Crystals of gE-gI bound to Fc were large, easily
reproduced, and had an ideal morphology, but diffracted
weakly to ;5-A˚ resolution. The complex crystals could not be
improved by changing the gE-gI or Fc construct or by
manipulating the crystals (summarized in Materials and
Methods). A 5.0-A˚ native data set was collected from the best
of several hundred crystals (Table S2) and used for molecular
replacement with the IgG Fc (pdb entry 1dn2) and CgE
structures as search models. A molecular replacement
solution was obtained when the Fc was positioned first
followed by two CgE molecules, one bound to each Fc chain.
Although the volume of the asymmetric unit could accom-
modate one to three gE-gI/Fc complexes [32], further searches
did not reveal additional Fc or CgE molecules, suggesting that
the gE-gI/Fc crystals contain a single 2:1 complex of gE-gI/Fc.
The resulting unusually high solvent content (79%) may
explain the limited resolution of the crystals.
The molecular replacement solution positions a CgE
molecule near the CH2-CH3 linker on each of the Fc chains
to make an approximately two-fold symmetric 2:1 gE-gI
complex (Figure 3A). The model allows sufficient space in the
unit cell for gI and NgE, which are unaccounted for in the
molecular replacement solution, and shows a plausible
packing arrangement including contacts between crystallo-
graphically related CgE molecules. Other features of the
molecular replacement solution suggest that it is correct.
First, two CgE molecules are bound to each Fc dimer, in
agreement with the observed stoichiometry of the gE-gI/Fc
interaction [12]. Second, although symmetry was not im-
posed, the solution is nearly perfectly two-fold symmetric
with the two-fold axis relating the two CgE molecules
coinciding with the Fc dyad axis and each CgE molecule
making similar contacts with the same region of an Fc chain.
Finally, the CgE molecules are positioned to interact with the
CH2-CH3 linker region of Fc, consistent with previous
biochemical analyses of the gE-gI/Fc interaction [12,21].
We used experimental phasing methods to independently
corroborate the molecular replacement model. A screen of
complex crystals that had been soaked in various heavy-atom
compounds resulted in four approximately isomorphous data
sets (Table S2). An initial analysis of a KIrCl3 derivative
identified five iridium sites located near the Fc molecule as
positioned in the molecular replacement solution, four of
which are related by the Fc dimer symmetry and two of which
make a chemically-plausible interaction with a methionine
(Met358) on each half of the Fc dimer (Figure 3B). Phases
were calculated after locating heavy atom sites for the other
derivatives (PIP, EMP, and Na2WO4) and used to find the
locations of 13 of 18 potential selenium-substituted methio-
nines in a crystal of SeMet-substituted gE-gI complexed with
Fc. A comparison of the identified selenium sites with the
molecular replacement model showed that eight of the 13
sites mapped to the eight methionine residues in CgE (Figure
3B). The clustering of all of the heavy atom sites around the
Fc molecule provides further support for only one copy of
the complex in the asymmetric unit. An overlay of the
molecular replacement model with a 5-A˚ heavy atom–phased
electron density map (Figure S2) shows overlap of the model
with electron density, including density for the N-linked
carbohydrates attached to the CH2 domain of Fc, and extra
density that likely corresponds to gI and NgE. Thus,
experimental phasing methods using a combination of
heavy-atom derivatives and SeMet-substituted crystals pro-
vides further confirmation of the molecular replacement
solution and validates its use as a model for the CgE/Fc
interaction in the context of the gE-gI/Fc complex.
Independent Prediction of the CgE/Fc Interaction
A complementary, computational approach was carried out
in parallel to the crystallographic work in order to model the
CgE/Fc interaction independently using an improved version
of RosettaDock [33,34]. RosettaDock uses real-space Monte
Carlominimization on both rigid-body and side-chain degrees
of freedom to identify the lowest free energy docked arrange-
ment of two protein structures and can be guided by biological
constraints when available. Docking was carried out in three
steps using the CgE structure and one chain of the two-fold
symmetric Fc used in themolecular replacement search. In the
first step, a global search through possible rigid-body
orientations of the CgE and Fc proteins was carried out with
the constraint that the CgE/Fc interface contains at least one of
the six residues in the consensus binding site on Fc (Met252,
Ile253, Ser254, Asn434, His435, and Tyr436) [19]. In similar
calculations on a number of other complexes [35], a small
number of closely relatedmodels that are significantly lower in
energy than others is observed, and in such cases, these low-
energy models are almost always close to the correctly docked
structure. The magnitude of the energy gap between the
correct models and other models is correlated with the
binding affinity of the interaction [33]. Perhaps because of
the relatively low binding affinity of the CgE/Fc interaction
(Figure 1C), we did not observe a significant energy gap in this
case, and hence could not confidently identify a single model
as correct based on the global docking calculations alone.
Instead, we proceeded by clustering the lowest-energy models
based on structural similarity and further pruning high-
ranked (large-sized) clusters by imposing a second constraint
that CgE interacts with both the CH2 and CH3 domains of Fc,
which has been observed for other interactions with the
consensus Fc binding site [19]. In the last step, the centers of
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the top five clusters were subjected to rigid-body and side-
chain torsion refinement, and the lowest energy models from
each refinement run were selected as the final predictions. Of
the five resulting models for the CgE/Fc interaction, one is
similar to the crystallographic model obtained by molecular
replacement and experimental phasing methods (Figure 3C).
Overview of the CgE/Fc Interface
The identification of the CH2-CH3 linker region of the IgG
Fc as the gE-gI binding site allows comparison with other
proteins that share similar binding sites on Fc. Thus, the gE-
gI/Fc complex structure provides a robust starting point for
understanding general features of the gE-gI interaction with
Fc, despite the caveats that small conformational changes in
the CgE or Fc structures and/or flexibility of the CH2-CH3
hinge cannot be addressed due to the limited resolution of
the structure.
The complex structure shows that CgE interacts with Fc
using regions of the first and second b-sheets, which
Figure 3. Experimentally Determined and Predicted Structures of CgE Bound to Fc
(A) Ribbon diagram of the top molecular replacement solution for a 2:1 CgE/Fc complex. CgE is shown in blue with the CDR loops highlighted in red,
and Fc is shown in green. Disulfide bonds are shown in yellow.
(B) Stereo view of the location of bound heavy atoms and SeMet residues superimposed on the CgE/Fc model derived by molecular replacement. CgE is
blue and Fc is green. The predicted position of the cell membrane (see text) is indicated by a gray line. A CgE molecule related by crystallographic
symmetry is shown in gray to demonstrate that the remaining portions of the gE-gI/Fc structure (NgE and gI) cannot occupy this location. The heavy-
atoms and SeMet residues are shown as spheres and colored by atom type (gray, mercury; red, tungsten; pink, iridium; orange, platinum; and teal,
SeMet). The heavy-atom and SeMet positions identified by Solve [56] were expanded by the crystallographic symmetry operators and translated to the
symmetry-equivalent positions that are closet to the CgE/Fc model.
(C) Stereo superposition of the crystallographically determined CgE/Fc complex and the complex predicted with RosettaDock [34] using the structures
of CgE and Fc. A half complex (one CgE and one chain of the Fc dimer) is shown with Fc in green, the CgE as positioned in the crystal structure in blue,
and the CgE as positioned by the docking prediction in pink. The root mean square deviation between the Ca atoms of the Rosetta-positioned CgE
molecule and each of the CgE molecules in the molecular replacement solution is 3.9 A˚, with the alignment being the best in the regions of CgE that are
closest to the CgE/Fc interface and poorest in the regions that are more distant from the binding site.
DOI: 10.1371/journal.pbio.0040148.g003
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correspond to the two b-sheets found in Ig V domains:
strands A and B9 and the B9–C and D–E loops in the DEBB9A
sheet and strands C, C9, and C99 and the C9–C99 loop in the
A9GFCC9C99 sheet (Figures 2C and 4). The third b-sheet does
not contact Fc and is distant from the CgE/Fc interface
(Figures 2C, 4A, and 4C). Of the CgE loops that correspond to
the CDR loops in Ig V domains, only CDR2 makes extensive
contacts with Fc (Figures 2C, 4A, and 4C).
The CH2-CH3 linker region on Fc has been identified as a
‘‘hot spot’’ for protein–protein interactions [19,20]. Crystal
structures are available for Fc complexed with four other
proteins, domain B1 of protein A [25], domain C2 of protein
G [28], rheumatoid factor [24], and FcRn [27], and with one
peptide that bind to this region [19]. Each of the Fc-binding
proteins is different in sequence and structure; however, their
binding interactions with Fc are similar, sharing a set of six
contact residues on Fc that have been referred to as the
consensus region [19,27]. Interface interactions involving
side-chain atoms of Fc residues Met252, Ile253, Ser254,
Asn434, His435, and Tyr436 and the adjacent peptide
backbone are found in each of the five FcR/Fc interfaces
[19,27], and are predicted to occur in the CgE/Fc interface
(Figure 4A). Likewise, the gE-gI/Fc structure suggests that the
interface with CgE contains at least two conserved inter-
actions with Fc that are found in three or more of the five
FcR/Fc interfaces [19,27]: hydrophobic packing onto Fc
His435 by gE Pro319 and gE Pro321, and hydrophobic
packing onto Fc Met252 and Fc Tyr436 by gE His247 (Figure
4A). Similar to the binding interfaces for the other five
proteins that bind the CH2-CH3 linker region of Fc [19,20,27],
the CgE/Fc interface is primarily nonpolar with a total of
;1800 A˚2 of buried surface area.
The gE-gI/Fc model is consistent with previous observa-
tions regarding the characteristics of Fc binding by gE-gI.
The finding that HSV-1 gE-gI does not bind an Fc mutant
containing six point mutations in the CH2-CH3 linker
(Met252 to Gly, Ile253 to Gly, His310 to Glu, His433 to
Glu, His435 to Glu, and Tyr436 to Ala) [12] that are all
predicted to be in the CgE/Fc interface can be explained by
both a reduction in the nonpolar interface area and an
unfavorable burial of charge in a hydrophobic environment
(Figure 4A). Similarly, the lack of gE-gI binding by allotypes
of human IgG3 that contain a His to Arg substitution at
position 435 compared to IgG1, IgG2, and IgG4 [21,22] is
likely due in part to the unfavorable energetic consequences
of burying an extended, charged residue in the small
hydrophobic pocket formed by gE residues Pro319 and
Pro321 (Figure 4A). A comparison of the sequences of the Fc
regions of the human, rabbit, and rat IgG subclasses,
focusing on the Fc residues that the gE-gI/Fc model predicts
to be important for Fc binding (Fc residues 252–258, 307,
309–311, 314–315, 382, 428, and 433–436), suggests a
molecular basis for the observation that gE-gI binds to
human and rabbit IgG, but not to rodent IgG [21,36]. Many
of the Fc residues in or near the interface are either
identical or conservatively substituted in human, rabbit, and
rat; however, differences at positions 252, 255, 258, and 382
(human/rabbit Met252, Arg255, Glu258, and Glu382 versus
rat Thr/Leu/Met252, Leu/Gln255, Lys258, and Gln/Lys/Thr/
Glu382) could perturb the interface such that gE-gI does not
bind rat IgG.
Mechanism of pH-Dependent Binding
Previous studies demonstrated a sharply pH-dependent
interaction for HSV-1–infected cells binding to rabbit IgG
[37] and for soluble gE-gI or gE monomers binding to human
Fc [12], such that binding occurs at neutral or slightly basic
pH but not at acidic pH. An analysis of the change in the
affinity of the gE-gI/Fc complex versus pH suggested that two
ionizable residues, likely histidines because they have a pKa
near neutral pH, participate in the pH-dependent affinity
transition [12]. The pH-dependent binding of Fc to CgE
(Figure 1A and 1B) suggests a direct role for CgE in
modulating the gE-gI/Fc interaction.
The CgE/Fc interface predicted from the gE-gI/Fc structure
contains four histidine residues that are candidates for
mediating the pH-dependent affinity transition: gE His247
near Fc Met252, Met428, and Tyr436; Fc His310 near gE
Pro321 and Ala340; Fc His433 near gE Ile249, Ala250, Arg316;
and Fc His435 near gE Pro319 and Pro320 (Figure 4A). The
residues in the vicinity of these histidines are generally
nonpolar, and protonation of a histidine residue at acidic pH
results in a positive charge that would be unfavorable if
buried in a hydrophobic environment or near another
positively charged residue. We predict that protonation of
at least two of the four histidines in the interface alters the
chemical properties of CgE and/or Fc such that the gE-gI/Fc
interaction is disrupted at acidic pH. The histidines at Fc
positions 310 and 435 appear to be more buried than those at
Fc position 433 and gE position 247, suggesting that Fc
His310 and Fc His435 are the two most likely histidines to
cause Fc dissociation upon protonation at acidic pH. pH-
dependent conformational changes in CgE and/or Fc could
also disrupt binding at acidic pH. Although we cannot rule
out local conformational variability that occurs as a function
of pH, it seems unlikely that CgE undergoes large changes in
conformation due to its relative compactness as a single
domain, and arguments against pH-induced conformational
changes in Fc have been made based on the similarity of Fc
crystal structures at pH values between 4.1 and 8.0 [27].
Structure-Based Interpretation of gE Mutagenesis Studies
To identify regions of gE involved in IgG binding or cell-to-
cell spread of HSV-1, a series of four- to five-residue
insertions were introduced into gE [7,14,17,18,38,39]. In the
absence of a 3-D structure, the effects of insertions on the
local and global conformations of a protein are unpredict-
able. However, the structures of CgE and a gE-gI/Fc complex
reported here can be used to identify which insertions are
likely to disrupt the CgE structure and which insertions are
likely to affect function.
Two studies used insertion mutagenesis to localize the IgG-
binding site on gE [14,17]. Five of 15 insertions that fall within
the CgE domain were introduced into surface-exposed loops
and are therefore unlikely to have global effects on the gE
structure (Figure 4B and 4C). Of these, three insertions
(following gE positions 235, 348, and 380) are located on the
top surface of CgE where they could interfere sterically with
interactions between CgE and the CH1-CH2 linker and/or Fab
domains of a bound IgG (Figures 4B and 5). The remaining
two surface-exposed loop insertions (following gE positions
333 and 339) are either in or close to the CgE/Fc interface
predicted by the gE-gI/Fc structure (Figure 4B and 4C). Ten
other insertions are more likely to have a global effect on gE
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Figure 4. Interfaces of CgE Involved in IgG Binding and Cell-to-Cell Spread
(A) A close-up of predicted side-chain interactions in the CgE/Fc interface. CgE side chains and peptide backbone are blue, Fc side chains and peptide
backbone are green, and disulfide bonds are yellow. Regions above and below the plane of the interaction have been omitted for clarity. Residues are
defined as interacting if one or more side-chain atoms from a residue in one protein are within 5 A˚ of a side-chain atom on the partner protein, which
includes residues 225, 245–247, 249–250, 256, 258, 311, 316, 318–322, 324, and 338–342 on CgE and 252–258, 307, 309–311, 314–315, 382, 428, and
433–436 on Fc. Histidine residues in the interface are indicated with red asterisks. Fc residue 382 is not visible in this orientation of the interface.
(B) Insertion mutants in CgE that disrupt Fc binding and/or viral spread mapped onto the CgE structure. The CgE backbone is shown in blue with
regions that are predicted to be in the CgE/Fc interface shown in magenta. The side chains shown are colored according to the effect that a four- or
five-residue linker inserted after them had on IgG binding and viral spread (blue, disrupt IgG binding and viral spread; green, disrupt IgG binding only;
and brown, disrupt IgG binding and not tested for viral spread [7,14,17,18,38,39]). Red asterisks indicate residues in surface-exposed loops.
(C) Secondary structure of HSV-1 CgE (residues 213–390) mapped on the amino acid sequence. Elements of secondary structure are shown above the
sequence with color-coding as in Figure 2A and 2B, and the three CDR loops (as defined in Ig V domain structures) are red. Cysteine residues are
highlighted in yellow, with disulfide bonds indicated by black lines between paired cysteines. The insertion mutagenesis data described in (B) is
depicted as colored arrows above the sequence with red asterisks indicating residues in surface-exposed loops. Residues that are in the predicted CgE/
Fc interface based on the crystallographic data are boxed in magenta.
DOI: 10.1371/journal.pbio.0040148.g004
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folding rather than a specific effect on IgG binding. These
include insertions into interior regions of CgE (those
following gE positions 256, 264, 302, 324, 355, and 371) or
insertions that change the spacing between the disulfide
bonds in the third b-sheet of CgE (those following gE
positions 277, 285, 291, and 297) (Figure 4B).
Insertion mutants in gE were also tested for their effects on
viral spread in cultured epithelial cells and HSV-1 infected
mice [7,17,18,38,39]. Although the mechanism of viral spread
is unknown, it has been hypothesized that the extracellular
domains of gE-gI bind to receptors at cell junctions, allowing
entry into adjacent cells [17,40]. Five insertions in CgE
affected viral spread as well as IgG binding, of which four
insertion mutants (following gE positions 277, 291, 348, and
380) were able to form a heterodimeric complex with gI [17].
As discussed above, the structural effects of insertions after
gE positions 277 and 291 are difficult to interpret due to their
location near disulfide bonds in the third b-sheet of CgE.
However, the insertions after gE positions 348 and 380 are
less likely to disrupt the overall structure of gE, therefore a
region of CgE encompassing these residues (Figure 4B) may
be involved in binding receptors required for cell-to-cell
spread of HSV-1.
A Model for the gE-gI/IgG Complex at the Cell Surface
The CgE/Fc model, taken together with the locations of
introduced heavy atoms and SeMet residues, provides insight
into the organization of the gE-gI/Fc ternary complex and its
orientation on a cell membrane. The position of the C-
terminus of CgE in the gE-gI/Fc complex structure, which is
;30 amino acids before the predicted transmembrane
domain, suggests that IgG bound by gE-gI is in an upright
orientation with respect to the membrane (Figure 5), similar
to FcaRI-bound IgA [41], but opposite to the orientation
predicted for antibodies bound by other cellular Fc receptors
such as FccRIII and FceRI [42–44].
The locations of NgE and gI in the gE-gI/Fc complex can be
approximated by an analysis of heavy-atom and SeMet sites
that are not accounted for by the CgE and Fc models. The
extra heavy-atom sites are located in a space that is bounded
by the CH3 domains of Fc on the top, the presumedmembrane
location on the bottom, and symmetry-related CgE molecules
on the sides (Figure 3B). Six of the sites that are not accounted
for by CgE or Fc, and thus attributed to NgE or gI, are related
by the Fc dyad axis (i.e., two sets of three heavy-atom sites),
consistent with the two-fold symmetry of the complex that
results from the inherent symmetry of the Fc dimer. These
results constrain NgE and the gI ectodomain to occupy a
position below CgE in the CgE/Fc model as shown in Figure
3B, in agreement with the presence of extra density that is not
accounted for by the models for CgE or Fc in experimental
electron density maps (unpublished data). Given that NgE is
covalently attached to the N-terminus of CgE, we predict that
NgE and gI, which is tethered to the membrane and interacts
with NgE [16], are both located below CgE, as depicted
schematically in Figure 5. The assignment of the NgE and gI
domains in the vicinity of the Fc CH3 domain is consistent
with the suggestion that additional binding surfaces on Fc
include CH3 domain residues 356 and 358 [45]. The same study
reported that allotypic changes in residue 214 in the IgG1 CH1
domain affected binding by gE-gI, which might be explained if
flexibility in the hinge region between the Fab arms and Fc
allowed contact of CH1 with the CgE portion of gE-gI. The
proposed positions of NgE and gI, together with the upright
orientation of Fc on a cell membrane, would allow the Fab
arms of an intact anti-HSV IgG to interact with HSV antigens
on the surface of the same membrane in a bipolar bridging
complex (Figure 5).
Figure 5. Model for gE-gI–Mediated Antibody Bipolar Bridging on the Cell Membrane
A ribbon diagram of the CgE/Fc portion of the gE-gI/Fc structure is shown with the approximate positions of the gI chain (red open oval) and NgE
domain (blue open oval) shown schematically. The predicted position of the cell membrane (see text) is indicated by a gray line. The upright position of
the Fc dimer suggests that the hinge region (green dashed line) and Fab arms (green ovals) of an intact antibody are located above gE-gI, where the
Fab combining sites could bind to a viral antigen (purple ovals) tethered to the same membrane as gE-gI.
DOI: 10.1371/journal.pbio.0040148.g005
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Discussion
Here we report the structures of CgE, an Fc-binding
fragment of the HSV-1 Fc receptor gE-gI, and a gE-gI
complex with Fc. Because we were able to solve the crystal
structure of the CgE subunit of the gE-gI ectodomain at high
resolution, the identification of CgE as a minimal Fc-binding
domain (Figure 1) made its structure useful for interpreting
the low-resolution gE-gI/Fc complex structure. An independ-
ent prediction of the complex structure using the coordinates
of the unbound CgE and Fc molecules revealed a close
agreement with the experimentally determined gE-gI/Fc
structure (Figure 3C), demonstrating the power of new
protein docking methods [33,34], and their potential for
facilitating difficult crystallographic problems.
The structure of the CgE domain of gE-gI represents a new
variant of the Ig superfamily that is distinct from the
structures of host FcRs and other known Fc-binding proteins
(Figure 2C and 2D). CgE contains two b-sheets with a Greek-
key folding topology similar to the topology of Ig V domains,
but includes an extra b-sheet that packs against the Ig V–like
portion of CgE (Figure 2A and 2B). Even within the region of
CgE that resembles an Ig V domain, CgE has a different
disulfide-bonding pattern and is longer and more open than
others in the Ig superfamily.
As revealed in the low resolution crystal structure of a gE-
gI/Fc complex, the CgE portion of gE-gI binds to Fc at the
CH2-CH3 interdomain junction (Figure 3A), consistent with
previous studies of the gE-gI/Fc interaction [12,21,23] and
allowing a comparison of the Fc-binding properties of CgE
with other proteins that bind to the same site on Fc [19,20,27].
An analysis of the CgE/Fc interface predicts that the six
residues that are the hallmark of the consensus binding site
on Fc [19,27] are also central to Fc binding by CgE (Figure
4A). In addition, the predominantly nonpolar CgE/Fc inter-
face includes predicted contacts that are chemically similar to
the conserved interactions with Fc found in several other
FcR/Fc interfaces [19,20,27].
As is also the case for FcRn binding to Fc, the gE-gI
interaction with Fc shows a sharp pH-dependent affinity
transition near neutral pH, but in the opposite direction:
whereas FcRn binds IgG at acidic pH in intracellular vesicles
but not at the slightly basic pH of the cell surface [46], gE-gI
binds IgG only at neutral or slightly basic pH [12]. Our analysis
of gE-gI/Fc affinity as a function of pH suggested that the pH-
dependent binding was due to protonation of two residues,
likely histidines, in Fc and/or gE [12]. As CgE also shows pH-
dependent binding to Fc (Figure 1), the CgE/Fc model derived
from the gE-gI/Fc structure can be used to identify candidate
residues involved in the pH-dependent interaction, which
include four histidines in the CgE/Fc interface (His247 on gE
and His310, His433, and His435 on Fc) (Figure 4A). Interest-
ingly, His310 andHis435 are two of the three Fc histidines that
have been identified as conferring a sharp pH-dependence to
the FcRn/Fc interaction [27]. In the FcRn/Fc complex these
histidines are buried in titratable salt bridges that are
disrupted at neutral or basic pH [27], whereas the histidines
in the CgE/Fc interface are buried in a hydrophobic environ-
ment that would be disrupted upon protonation of the
histidines at acidic pH, resulting in the acquisition of a
positive charge. The distinct roles proposed for these Fc
histidines depending on the nature of the Fc-binding protein
is an example of the versatility of the consensus binding site at
the Fc CH2-CH3 interdomain junction.
The model for CgE binding to Fc derived from the crystal
structures of CgE and a gE-gI/Fc complex can be used to gain
insight into the regions of CgE that are implicated in cell-to-
cell spread of HSV. Mapping of insertion mutations in gE that
affect viral spread [17,18,39] on the CgE and gE-gI/Fc complex
structures identifies a region of CgE that could interact with
receptors for gE-gI (Figure 4B). Although the structure-based
interpretation of the insertion mutagenesis studies on CgE
suggests that the surface of the protein involved in cell-to-cell
spread of the virus is distant from the Fc-binding interface
(Figure 4B), it is currently unclear whether the cell-to-cell
spread and IgG binding functions of gE-gI are correlated.
Viruses with insertions in gE after positions 333 and 339,
which are at or near the crystallographically observed CgE/Fc
interface, are disrupted for IgG binding but spread normally,
suggesting that IgG binding is not required for cell-to-cell
spread [7,17,38]. Consistent with this possibility, cell-to-cell
spread has been observed in the absence of IgG when
extracellular spread is blocked by the presence of solid
matrices. However, the extent of cell-to-cell spread is
influenced by the presence of anti–HSV-1 IgGs that contain
Fc regions that can bind to gE-gI [47], suggesting a role for
antibody bipolar bridging. A positive correlation between
cell-to-cell spread and antibody bipolar bridging could be
explained by a mechanism involving increased endocytosis of
gE-gI bound to anti-HSV/HSV antigen complexes, dissocia-
tion and degradation of anti-HSV IgG in acidic vesicles, and
transport of gE-gI to the trans-Golgi network [48,49], where it
would be available for viral packaging [50].
The crystallographic data can be used to deduce a model
for how IgG binds gE-gI on the surface of virions or infected
cells, whereby CgE binds the consensus Fc-binding site on
each half of the Fc dimer, and gI and the NgE are located
underneath the CgE domain between the CH3 domains of Fc
and the membrane (Figure 5). Critical to interpretation of gE-
gI recognition of IgG in vivo is the prediction that intact IgG
is bound in an ‘‘upright’’ orientation, with the CH3 domains
of the Fc closest to the membrane and the Fab arms furthest
away. Similarly, FcaRI binds the IgA Fc in an upright
orientation [41], whereas in other host FcR/Ig complexes of
known structure (the FccRIII/Fcc and FceRI/Fce complexes),
the receptor-bound antibody is oriented with its Fabs closest
to the membrane [42–44]. The upright orientation of the Fc
and the positioning of the bulk of gE-gI to the side and
underneath the Fc leave sufficient space for the Fab arms of
an anti-HSV IgG bound to gE-gI to interact with antigens
using antibody bipolar bridging (Figure 5).
The gE-gI binding site on Fc does not directly overlap with
the binding sites for the FccRs or the C1q component of
complement, which bind on or near the CH2 domain
[43,44,51], thus the structure of the gE-gI/Fc complex does
not directly suggest how gE-gI binding to the Fc region of IgG
leads to evasion of FccR- and complement-mediated immune
responses. However, an anti-HSV antibody that is bound to
both gE-gI and an HSV antigen on the surface of an infected
cell could be sterically hindered from also binding to host
FccRs or C1q due to the close proximity of the proteins in the
antibody bipolar bridging complex. Evasion of the host
immune response may also be facilitated by the pH sensitivity
of the gE-gI/Fc interaction [12]. The demonstration that the
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gE-gI/Fc structure is compatible with antibody bipolar
bridging (Figure 5) raises the possibility that anti-HSV IgG/
HSV antigen complexes interacting with gE-gI on the surface
of infected cells are endocytosed by gE-gI and degraded in the
lysosomes after dissociation at acidic pH, resulting in
destruction of antiviral antibodies and removal of viral
antigens from the cell surface.
Materials and Methods
Purification and expression of CgE. Our numbering scheme
defines the first residue of the hydrophobic leader peptide in the
immature gE protein as residue 1. N-terminal sequencing and mass
spectroscopy analyses of degradation products present in a prepa-
ration of purified gE-gI suggested that gE residues 210–395 comprise
a stable domain (unpublished data) in agreement with previous
proteolytic analyses of soluble gE-gI that showed that gE was cleaved
into N- and C-terminal fragments with a domain boundary in the
vicinity of gE residue 208 [16]. Standard PCR-based subcloning
techniques were used to insert a fragment of the gE gene from HSV
strain KOS, encoding residues 213–390, downstream of the p10
promoter in the pAcUW51 baculovirus transfer vector (PharMingen,
San Diego, California, United States). The expression vector also
encoded the gE hydrophobic leader peptide N-terminal to the
inserted fragment and a C-terminal Factor Xa cleavage site and 6x-
His tag. Recombinant baculovirus stocks were generated by cationic
liposome cotransfection of the expression plasmid with linear wild-
type baculovirus DNA in High 5 insect cells (Invitrogen, Carlsbad,
California, United States) as described by the manufacturer. Insect
cell supernatants containing secreted CgE were buffer-exchanged
into nickel-binding buffer (40 mM Tris [pH 8], 300 mM NaCl, 10 mM
imidazole) and passed over a Ni-NTA agarose column (Qiagen,
Valencia, California, United States). Bound protein was eluted in
buffer containing 40 mM Tris (pH 8), 300 mM NaCl, and 250 mM
imidazole, and further purified by size-exclusion chromatography on
a Superdex 75 HiLoad 16/60 column (GE Healthcare, Piscataway, New
Jersey, United States) that was equilibrated in 10 mM HEPES (pH 7.6)
and 150 mM NaCl. Peak fractions were concentrated and buffer
exchanged into 10 mM HEPES (pH 7.5). The expression of SeMet-
substituted CgE was performed using an adaptation of published
protocols [52,53]. Briefly, insect cells that were infected with the CgE-
recombinant virus were grown in Ex-Cell 400 media (JRH Bioscien-
ces, Lenexa, Kansas, United States) for 16 hours, pelleted, and then
resuspended in Sf-900 II SFM media (Invitrogen) supplemented with
30 mg/l of L-cysteine (Sigma, St. Louis, Missouri, United States). After
4 h, 100 mg/l SeMet (Sigma) was added, and supernatants were
harvested after 28 h and processed as described above for native CgE.
Biosensor studies of CgE/Fc binding. Surface plasmon resonance
studies were performed using a BIAcore 2000 instrument (Biacore,
Uppsala, Sweden). In this system, binding between a molecule
coupled to a biosensor chip (the ‘‘ligand’’) and a second molecule
injected over the chip (the ‘‘analyte’’) results in changes in the surface
plasmon resonance signal that are read out in real time as resonance
units [54]. wtFc and nbFc, both derived from human IgG1, were
purified from CHO cell supernatants as described previously [12] and
immobilized on a CM5 biosensor chip (Biacore) using primary-amine
coupling as described by the manufacturer. Equilibrium binding data
for CgE binding to wtFc (coupling density, 440 resonance units), nbFc
(coupling density, 405 resonance units), and a mock-coupled flow cell
were collected for a CgE concentration series (three-fold dilutions of
CgE from 30 lM to 5 nM) at pH 8 (50 mM HEPES [pH 8.0], 150 mM
NaCl, 3 mM EDTA, 0.005% [vol/vol] P-20 surfactant) and pH 6 (50
mM sodium phosphate [pH 6.0], 150 mM NaCl, 3 mM EDTA, 0.005%
[vol/vol] P-20 surfactant). After each injection of CgE, a 30-s injection
of 250 mM di-ammonium hydrogen citrate (pH 5.0) was used to
disrupt the interaction and restore the surface.
Sensorgrams were processed and analyzed using the Scrubber
software package (Biologic Software Pty. Ltd., http://www.biologic.
com.au). KD values were determined by plotting the equilibrium
response in the plateau region versus the logarithm of the CgE
concentration for each injection and fitting the data to a single-site
binding model. Although Fc contains two potential binding sites for
CgE, the interaction was too weak to accurately fit the data to a two-
site binding model.
Crystallization and structure determination of CgE. Crystals of CgE
were grown by hanging-drop vapor diffusion in drops containing
equal volumes of ;25 mg/ml CgE and well solution (100 mM Tris [pH
8.5], 28%–32 % [wt/vol] PEG 4000). Microseeding increased the
frequency of obtaining single crystals. SeMet-substituted CgE crystals
were grown in conditions similar to the native crystals with the
addition of 10 mM MgCl2 in the well solution, which decreased the
disorder that was often observed in the diffraction of the native
crystals. All crystals were cryoprotected in well solution with an
additional 15% PEG 4000, added in 5% increments, and stored in
liquid nitrogen prior to data collection at180 8C. Native and SeMet
data were collected to 1.78 A˚ and 2.0 A˚, respectively (Table S1). Data
were processed and scaled with the HKL suite (HKL Research,
Charlottesville, Virginia, United States) [55], and the space group was
determined as P21 with 2 molecules in the asymmetric unit.
Phases were derived from a three-wavelength multiple anomalous
dispersion experiment using SeMet-substituted CgE crystals. Solve
[56] was used for local scaling of the data, location and refinement of
Se positions, and phasing (figure of merit of 0.36 from 30–2 A˚)
followed by Resolve [57,58] for solvent flattening and automated
model building (60% of the asymmetric unit was built by Resolve
[57,58]). The remainder of the model was built using O [59]. Multiple
rounds of refinement, which included a bulk-solvent correction and
positional refinement, simulated annealing with torsion angle
dynamics, and individual B-factor refinement, were carried out with
CNS [60] using the MLHL target with the SeMet data and phases and
then switching to the MLF target with the native data. The final
model was refined to 1.78 A˚ (Rcryst ¼ 19.8%, Rfree ¼ 22.0%) and
includes gE residues 218–390, residues 1–5 (first molecule) and 1–6
(second molecule) of the C-terminal Factor Xa recognition site, and
275 water molecules (Table S1). A Ramachandran plot calculated
using Procheck [61] showed that for nonglycine residues 87.1% are in
the core regions, 12.2% are in the allowed regions, 0.6% are in the
generously allowed regions, and 0% are in the disallowed regions.
Crystallization and structure solution of a gE-gI/Fc complex.
Various forms of gE and the gE-gI heterodimer were subcloned,
expressed, and purified from baculovirus-infected insect cell super-
natants by nickel affinity and/or IgG affinity and gel-filtration
chromatography as described previously [12]. Two recombinant
forms of the Fc fragment of IgG1, wtFc and heterodimeric Fc, which
contain two and one gE-gI binding sites, respectively, were also
produced in CHO cells and purified as described previously [12].
Crystallization trials were conducted for various forms of CgE, gE,
and gE-gI (including CgE [residues 213–390], gE [residues 21–419],
gE2 [residues 21–390], gE-gI [gE plus gI residues 21–266], gE2-gI2A
[gE2 plus gI residues 21–208], and gE2-gI2B [gE2 plus gI residues 21–
201]) both alone and complexed with wtFc or heterodimeric Fc. The
only isolated protein to crystallize was CgE (described above), and the
only complex of the six possible gE-gI/Fc complexes that crystallized
was one that contained gE residues 21–419 and gI residues 21–266
and wtFc (residues 223–447). The complex crystals grew from drops
containing a 2:1 molar ratio of gE-gI and wtFc mixed with an equal
volume of well solution (0.1 M MES [pH 6.0] or 0.1 M HEPES [pH 7.0]
and 0.9–1.1 M sodium malonate), resulting in a final pH of
approximately 7.5. Microseeding increased the reproducibility of
crystal growth.
Complex crystals were prepared for data collection by transferring
into drops containing either increasing concentrations of sodium
malonate in 0.2 M increments up to 2 M, or 1.4 M sodium malonate
plus increasing concentrations of glycerol in 5% (vol/vol) increments
up to 15% and then stored in liquid nitrogen prior to data collection
at 180 8C. Hundreds of crystals were screened for diffraction using
synchrotron radiation at Stanford Synchrotron Radiation Laboratory
beamlines 9–1 and 9–2. The best crystal diffracted anisotropically to
;4.2 A˚ along the l axis and ;5.4 A˚ along the h and k axes. Complex
crystals were also screened for the effects of various cryoprotectants,
crystallization additives, enzymatic deglycosylation of N-linked and
O-linked sugar moieties on gE-gI, dehydration conditions, and
annealing protocols on the diffraction; however, none of these
variables significantly improved the quality of the diffraction.
A native dataset, which was collected on a complex crystal
containing gE-gI that had been treated with O-glycosidase (Roche
Applied Science, Indianapolis, Indiana, United States), was processed
and scaled to 5.0 A˚ in the space group P41212/P43212 with the HKL
suite [55] and MOSFLM/Scala [62] (Table S2). Based on average
volume to mass ratio of protein crystals [32], the asymmetric unit
contained either one, two, or three copies of the 2:1 gE-gI/Fc
complex, corresponding to 79%, 58%, or 37% solvent content,
respectively.
A molecular replacement search was performed to 5.4 A˚ using the
program Phaser [63,64]. The search models were the CgE structure
(reported in this paper) truncated after residue 390 (the last residue
in gE before the Factor Xa cleavage site) and the human IgG Fc
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structure (pdb entry 1dn2), which together account for 45% of the
total molecular mass of the gE-gI/Fc complex. Initial molecular
replacement trials with the Fc coordinates clearly distinguished
between the enantiomeric space groups P41212 and P43212 (log-
likelihood gain of 44.7 for P41212 versus 92.6 for P43212), with P43212
being the correct space group. Subsequent searches for CgE
molecules, which were carried out in the space group P43212 with
the position of Fc fixed, yielded a log-likelihood gain of 282 for the
first CgE and 578 for the second CgE. The positions of the first and
second CgE molecules on each Fc chain were almost perfectly related
by the dyad axis of the Fc, thus the CgE/Fc interface on each half
complex is similar, with a slight translational shift of ;2 A˚ for the
second CgE molecule relative to the first. Because the asymmetric
unit could contain one, two, or three 2:1 complexes, attempts were
made to locate additional complexes, including searching for addi-
tional Fc molecules, searching for half complexes of one CgE and one
Fc chain, and searching for additional 2:1 complexes. However, no
additional CgE/Fc complexes were located, suggesting that the
asymmetric unit contains one 2:1 CgE/Fc complex and ;79% solvent.
For heavy-atom screening, complex crystals were soaked in 38
different heavy-atom compounds for between 18 h to 7 d, back-
soaked for 2–3 h during cryopreservation, and screened for
diffraction and fluorescence at the appropriate energies.
Four datasets, which were collected near the f 99 peak energies for
crystals that were soaked in KIrCl3, PIP, EMP, or Na2WO4, were
isomorphous with the native data set (Table S2). All of the derivative
data sets were indexed, reduced and scaled with MOSFLM, Scala, and
Scaleit [62], respectively, before being input into Solve [56] with the
native data set. Using the KIrCl3 and native data sets, Solve [56]
initially identified five Ir atoms, whose locations mapped onto or near
the position of the Fc molecule predicted by molecular replacement,
that were used to calculate phases. Cross-difference Fourier
calculations were performed for the PIP, EMP, and Na2WO4
derivatives, using the KIrCl3 phases to locate the heavy-atom binding
sites for each derivative. Electron density maps were calculated using
phases that were determined by combining all of the data sets in
Solve [56] (figure of merit of 0.42 from 45–5 A˚).
SeMet-substituted gE-gI was expressed in baculovirus insect cells as
described above for CgE and purified as described above for native
gE-gI. Crystallization and cryopreservation for crystals of the SeMet-
substituted gE-gI/Fc complex were as described above for the native
complex crystals. Multiple anomalous dispersion data were collected
at the peak, inflection, and remote energies and processed using
MOSFLM and Scala [62] (Table S2). The SeMet data for each of the
three wavelengths was input into Solve [56] with the KIrCl3 or four-
derivative multiple isomorphous replacement with anomalous
scattering phases, resulting in 13 Se sites (of a possible 18). Analysis
of the sites reveal that eight Se positions map close to methionines in
the CgE molecules as positioned in the molecular replacement
solution, and 12 of the 13 sites are related by the Fc dyad axis (i.e., two
sets of six sites). Phases determined in Solve [56] using only the 13 Se
sites had a figure of merit of 0.41 from 30–6 A˚. Residues in the
interface are defined as those within 5 A˚ of a side-chain atom on the
opposing protein.
Theoretical prediction of the CgE/Fc interaction. Prediction of the
CgE/Fc interaction was done using the RosettaDock protocol as
described [34]. Out of the initial population of 903,800 models
generated in global docking calculations, the 200 lowest energy
models that included at least one of the six ‘‘hot-spot’’ residues [19] at
the predicted interface were clustered, and the clusters were ranked
by the cluster size (the number of models within each cluster). In the
next stage, a second constraint was imposed requiring that CgE make
contact with both the CH2 and CH3 domains of the Fc protein, as
observed for other proteins binding to the Fc ‘‘hot spot,’’ [19] which
resulted in pruning some of the top-ranking clusters. The centers of
each of the top five remaining clusters were then subjected to more
extensive local rigid-body and side-chain refinement to produce five
final predicted structures, of which one matches the crystallographic
model of the CgE/Fc interaction (Figure 3C) (model ‘‘d,’’ described
below). In the five RosettaDock-predicted CgE/Fc complexes, differ-
ent regions of CgE are used to bind the consensus region of Fc (model
‘‘b,’’ CgE residues in strand A, A-A9 linker, strand A9, strand B9, CI–
CI9 linker, strand G, G–I99 linker, and strand I99; model ‘‘c,’’ CgE
residues in strand A, A–A9 linker, B–B9 linker, strand B9, CI–CI9
linker, C9–C99 linker, strand G, and strand I99; model ‘‘d,’’ which
resembles the molecular replacement solution, CgE residues in strand
A, B–B9 linker, strand B9, strand C, strand C9, C9–C99 linker, and D–E
linker; model ‘‘e,’’ CgE residues in CI9–C9 linker, strand C99, C99–D
linker, strand D, and E–F linker; and model ‘‘f,’’ CgE residues in
strand C, C–CI linker, CI–CI9 linker, strand C9, and strand C99, C99–D
linker, E–F linker) (unpublished data).
Supporting Information
Figure S1. Comparison of CgE with Its Closest Structural Homologs
Stereo superposition of the Ca atoms of (A) CgE (blue) with an Fv
heavy chain (magenta; pdb entry 1mfa), and (B) CgE (blue) with
coxsackie virus and adenovirus receptor domain 1 (green; pdb entry
1eaj). Disulfide bonds are in yellow.
Found at DOI: 10.1371/journal.pbio.0040148.sg001 (2.1 MB JPG).
Figure S2. Experimental Electron Density Map
The molecular replacement solution is shown as a Ca trace super-
imposed on the experimentally phased electron density map. CgE is
in blue with the CDR loops colored red, and Fc is in green with the
carbohydrates in gray. A stereo view of the electron density within 5
A˚ of the molecular replacement model is shown for (A) Fc and (B) the
CgE/Fc interface.
Found at DOI: 10.1371/journal.pbio.0040148.sg002 (4.3 MB JPG).
Table S1. Data Collection and Refinement Statistics of CgE
Found at DOI: 10.1371/journal.pbio.0040148.st001 (74 KB DOC).
Table S2. Data Collection and Phasing Statistics of a gE-gI/Fc
Complex
Found at DOI: 10.1371/journal.pbio.0040148.st002 (74 KB DOC).
Accession Numbers
The Research Collaboratory for Structural Bioinformatics Protein
Data Bank accession numbers (http://www.rcsb.org/pdb) are 2GIY for
the CgE structure and 2GJ7 for the gE-gI/Fc complex structure.
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